Org 5593594814Högbergsgatan 39 4 Tr Lgh 1401Research and experimental development on natural sciences and engineering · NACE 7210Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
-11% vs 2023
Equity ratio
97.0%
Financial strength
Net profit 2024
SEK -1,1M
-11% vs 2023
EBITDA — year on yearSEK millionsKey figuresAnnual report 2024
Revenue
SEK 0
—
EBITDA
SEK -1,1M
-11%
Net profit
SEK -1,1M
-11%
Total assets
SEK 2M
-35%
Equity
SEK 1,9M
-36%
Employees
0
—
Company information
Legal name
Zytox Therapeutics AB
Org number
5593594814
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11 januari 2022
Share capital
SEK 28 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva läkemedelsutveckling och därmed förenlig verksamhet
Contact
Address
Högbergsgatan 39 4 Tr Lgh 1401
Email
marianne.hansson@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.